CTRI/2018/03/012389已完成未知
An open label clinical study to evaluate the safety, tolerability and glycemic index of COCOZEN in healthy volunteers
Akay Flavours and Aromatics Private Limited0 个研究点目标入组 20 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1)Males and females in the age 18 â?? 55 years
- •2)Normal physical condition as determined by the investigator
- •3)Subject with body mass index 18.5- 27 Kg/m2 (Both inclusive)
- •4)Must be willing to comply with all study requirement
- •5)Subject should agree to avoid any kind of herbal formulations during the study period
- •6)Must be able and willing to provide a written informed consent.
排除标准
- •1)Subject with history of cardiovascular, Type 2 Diabetes mellitus, pulmonary, hepatic and renal problems
- •2)Subjects who are currently under any kind of long term medication
- •3)Subjects with a known allergy to herbal products
- •4)Chronic drinkers
- •5)Subject with a habit of smoking
- •6)Subjects with abnormal biochemical or haematological values
- •7)Subjects with abnormal blood pressure
- •8)Pregnant or Lactating Women
- •9)Any condition that in Opinion of the Investigator, does not justify the Subjectsâ?? participation in the study.
研究者
相似试验
尚未招募
4 期
Clinical efficacy and safety of Isha BalmCTRI/2018/02/011819Isha Arogya pvt ltd
已完成
不适用
CelWel in Long CovidCTRI/2022/12/048144Carmel Research Consultancy Private Limited15
已完成
不适用
Clinical Study For Patients Requiring Tube FeedingCTRI/2019/12/022446Modi Mundi Pharma Private Limited15
已完成
不适用
Clinical Study For Hospitalized Patients Requiring isocaloric formulafor enteral tube feedingCTRI/2020/09/027831Modi Mundi Pharma Private Limited15
进行中(未招募)
1 期
An open-label clinical study to evaluate the safety and antiepileptic activity of ganaxolaone in treatment of patients diagnosed with infantile spansms.EUCTR2006-004286-33-PLMarinus Pharmceuticals, Inc.54
